Only 26/63 patients with Alzheimers’s disease dementia had biological confirmation of Alzheimer’s disease biomarkers, which confirmed presence of amyloid and tau positivity. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.